Sophie M Perrin

Sophie M Perrin has extensive experience in the pharmaceutical industry, currently serving as Associate Director at Zentalis Pharmaceuticals since February 2021. Prior to this role, Sophie held positions at Bristol Myers Squibb from November 2014 to February 2021, advancing from Principal Scientist to Sr Principal Scientist. Sophie's career began at Celgene, where tenure spanned from December 2001 to November 2014, progressing from Scientist I through to Sr Scientist. Academically, Sophie earned a Ph.D. in Organic Chemistry from UC San Diego and attended the University of Detroit Mercy (UDM).